Acorda Therapeutics, Inc. ACOR was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $1.68 –$2.75 in the past one-month time frame, witnessed a sharp increase yesterday.Over the last 30 days, the Zacks Consensus Estimate for the current quarter has remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.Acorda Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%. Acorda Therapeutics, Inc. Price Acorda Therapeutics, Inc. price | Acorda Therapeutics, Inc. QuoteA better-ranked stock in the Medical - Biomedical and Genetics industry is Amarin Corporation PLC AMRN, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.Is ACOR going up? Or down? Predict to see what others think: Up or DownJust Released: Zacks’ 7 Best Stocks for Today Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.6% per year.These 7 were selected because of their superior potential for immediate breakout.See these time-sensitive tickers now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Acorda Therapeutics, Inc. (ACOR): Free Stock Analysis Report Amarin Corporation PLC (AMRN): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research